SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

OPTIS™ Imaging Systems

OCT Imaging and Coronary Physiology on One Platform

OPTIS™ Imaging Systems
About

OPTIS™ Imaging Systems

OCT imaging and coronary physiology on one platform

Abbott's OPTIS™ Imaging Systems offer high resolution OCT intravascular imaging and coronary physiology (RFR*/FFR) on one platform to guide PCI with informed decisions. The OPTIS™ Imaging Systems, Integrated System and Mobile System, powered by the OCT Imaging Software which now includes coronary physiology measurement, used with the Dragonfly OpStar™ Imaging Catheter represent Abbott’s intravascular imaging products designed for imaging of coronary arteries.

OPTIS Integrated System

OPTIS™ Integrated System set up. Components shown include Wi-Box™ AO Transmitter, DOC, TSC and OCT user interface displayed on Boom Monitor

When interventional cardiologists (ICs) have access to sophisticated OCT imaging and coronary physiology in the cath lab, data show improved outcomes during PCI stent procedures:1-3

The OPTIS™ Imaging Systems are seamlessly integrated into the cath lab and PCI workflow. Benefits include:

Access to OCT and RFR*/FFR on one system for informed PCI decision-making

  • The OPTIS™ Imaging Systems enable OCT imaging and coronary physiology measurement using resting-full cycle ratio (RFR) and fractional flow reserve (FFR). This integration provides a versatile system for the multiple modalities used during PCI, reducing set-up time and eliminating clutter from multiple cable and components.
  • For a standalone physiology solution, the QUANTIEN™ Measurement System offers full integration without time-consuming setup or lab downtime.

Automated OCT software features inform aspects of PCI planning:

  • Rapid image processing: The OPTIS™ Imaging Systems have a less than a three second pullback speed enabling fast image acquisition and immediate interpretation of lesion morphology. Images appear on the OCT interface screen right after the pullback.
  • Simultaneous angio and OCT co-registration: OCT software provides real time instantaneous synchronization of angiographic and OCT images for side-by-side viewing to help physicians clearly:
      1) Identify stenotic lesion(s) and
      2) Mark stenotic locations to facilitate accurate stent placement
  • Post-PCI optimization information on one screen
    The OCT software provides post-PCI information on one screen (apposition and expansion indicators, dissection visualization) to guide a user step-by-step to optimize PCI to ensure adequate stent expansion.
OCT software features

Mark stenotic locations within the coronary anatomy as shown with the orange circle

OCT software feature post-PCI information on one screen

The OCT software provides post-PCI information on one screen

*RFR is available with AptiVue™ Imaging Software and Ultreon™ 1.0 Software.

 

References

Refer to Instructions For Use (IFU) for additional information.

  1. Jones DA, et al Angiography alone versus angiography plus optical coherence tomography to guide percutaneous coronary intervention. JACC: Cardiovasc Interv. 2018;11(14):1313-1321. doi: 10.1016/j.jcin.2018.01.274.
  2. Pijls, N., et al. 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. JACC Vol. 56, No. 3, 2010.
  3. Ahn JM, et al. IRIS FFR: prognostic performance of five resting pressure-derived indexes of coronary physiology. TCT 2018.
  4. Bezerra H, et al. Analysis of changes in decision-making process during optical coherence tomography-guided percutaneous coronary interventions: new insights from the LightLab Initiative. EuroPCR 2020.
  5. Croce K. The benefits of optical coherence tomography in the cath lab. Cardiovasc News. 2020;59:15.

MAT-2103698 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0